The antibody therapy developer closed a $100m round co-led by Lilly Asia Ventures that will fund phase 3 clinical studies for its lead drug candidates.

Medison Pharma and Partners Healthcare could be in line for exits after the haematological and musculoskeletal disorder therapy developer filed to raise $86.3m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The pharmaceutical firm was among the investors in a series G round that valued precision medicine technology provider Tempus at $5bn.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Covid-19 Therapeutics Accelerator has launched with $125m to find treatments for the pandemic, $25m of which came from Mastercard.

Ping An-backed health services provider Fullerton could theoretically seek an acquisition deal or spin off its digital division.

UnityPoint’s corporate VC unit backed the series C round for Vida Diagnostics, a lung disease imaging technology provider.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.